Clinical characteristics and outcomes of acute ischemic stroke in Hiroshima city during the COVID-19 era from HARP study
Tomohisa Nezu(Hiroshima University), Hirofumi Maruyama(Hiroshima University), Tomoyuki Kono(Hiroshima University), Yoshihiro Kiura(Hiroshima Prefectural Hospital), Toshinori Matsushige(Hiroshima City Asa Citizens Hospital), Daizo Ishii(Hiroshima University), Nobuyuki Hirotsune(Hiroshima City Asa Citizens Hospital), Hiroshi Yamashita(Hiroshima City Asa Citizens Hospital), Atsushi Tominaga(Hiroshima Prefectural Hospital), Tatsuya Mizoue(National Center for Global Health and Medicine), Nobutaka Horie(Hiroshima University), Shiro Aoki(Hiroshima University), Ryo Shimomura(Hiroshima University), Eiji Imamura, Naoto Kinoshita(National Cerebral and Cardiovascular Center), Eiichi Nomura, Hiromitsu Naka, Naoyuki Hara(Hiroshima University), Kazuhide Ochi(Hiroshima University)
Cited by 0
Related Papers
Carotid Intima-Media Thickness for Atherosclerosis
|Journal of Atherosclerosis and Thrombosis|2015|311
Transplanted Stem Cell-Secreted Vascular Endothelial Growth Factor Effects Poststroke Recovery, Inflammation, and Vascular Repair
|Stem Cells|2011|238
The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study
|EBioMedicine|2015|124
Pretreatment ASPECTS on DWI predicts 3-month outcome following rt-PA
|Neurology|2010|106